Broadfin Capital’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$15.6M	Buy	3,060,923 +1,476,998	+93%	+$7.81M	3.87%	14
2019 Q3	$8.01M	Buy	+1,583,925	New	+$7.9M	2.51%	20
2018 Q2	–	Hold	0	–	–	–	68
2018 Q1	–	Hold	0	–	–	–	60
2017 Q3	–	Sell	-1,000,000	Closed	-$6.79M	–	57
2017 Q2	$6.79M	Sell	1,000,000 -998,531	-50%	-$7.37M	0.98%	31
2017 Q1	$18.9M	Sell	1,998,531 -6,952,638	-78%	-$69.4M	2.65%	15
2016 Q4	$77.3M	Hold	8,951,169	–	–	8.76%	2
2016 Q3	$56.7M	Hold	8,951,169	–	–	5.38%	4
2016 Q2	$37.8M	Hold	8,951,169	–	–	4.19%	7
2016 Q1	$39M	Hold	8,951,169	–	–	4.53%	6
2015 Q4	$54.9M	Hold	8,951,169	–	–	3.94%	8
2015 Q3	$51.2M	Hold	8,951,169	–	–	4.08%	7
2015 Q2	$66.8M	Hold	8,951,169	–	–	4.39%	7
2015 Q1	$53.5M	Hold	8,951,169	–	–	4.27%	5
2014 Q4	$67.7M	Hold	8,951,169	–	–	5.93%	3
2014 Q3	$46.5M	Buy	8,951,169 +2,315,000	+35%	+$11.5M	4.88%	4
2014 Q2	$28.6M	Buy	6,636,169 +1,050,000	+19%	+$4.01M	2.79%	9
2014 Q1	$22.8M	Buy	5,586,169 +1,586,169	+40%	+$8.11M	2.21%	11
2013 Q4	$21.3M	Buy	4,000,000 +520,652	+15%	+$2.29M	2.81%	12
2013 Q3	$17.5M	Sell	3,479,348 -21,267	-0.6%	-$115K	3.1%	12
2013 Q2	$15.6M	Buy	+3,500,615	New	+$15.7M	3.05%	12